CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 38 filers reported holding CONSTELLATION PHARMCETICLS I in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $2,036,000 | -30.9% | 60,252 | -52.2% | 0.00% | – |
| Q1 2021 | $2,946,000 | +84.0% | 125,963 | +126.6% | 0.00% | – |
| Q4 2020 | $1,601,000 | +28.0% | 55,577 | -10.0% | 0.00% | – |
| Q3 2020 | $1,251,000 | +3.0% | 61,775 | +53.0% | 0.00% | – |
| Q2 2020 | $1,214,000 | +240.1% | 40,377 | +256.0% | 0.00% | – |
| Q1 2020 | $357,000 | +33.2% | 11,341 | +99.8% | 0.00% | – |
| Q4 2019 | $268,000 | +523.3% | 5,676 | -16.0% | 0.00% | – |
| Q3 2019 | $43,000 | -43.4% | 6,758 | +8.2% | 0.00% | – |
| Q2 2019 | $76,000 | +49.0% | 6,246 | +66.8% | 0.00% | – |
| Q1 2019 | $51,000 | +200.0% | 3,744 | -13.2% | 0.00% | – |
| Q4 2018 | $17,000 | +142.9% | 4,313 | +324.9% | 0.00% | – |
| Q3 2018 | $7,000 | – | 1,015 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP, LLC | 3,034,083 | $37,259,000 | 42.17% |
| Svennilson Peter | 4,677,939 | $57,446,000 | 16.42% |
| VHCP Management II, LLC | 726,677 | $8,924,000 | 2.81% |
| Casdin Capital, LLC | 1,523,960 | $18,714,229,000 | 1.75% |
| P.A.W. CAPITAL CORP | 120,000 | $1,474,000 | 1.59% |
| Cormorant Asset Management, LP | 1,271,685 | $15,616,000 | 0.90% |
| VHCP Management III, LLC | 66,667 | $819,000 | 0.38% |
| Orbimed Advisors | 835,842 | $10,264,000 | 0.16% |
| Hillhouse Capital Management | 317,921 | $3,904,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 183,600 | $2,255,000 | 0.08% |